# Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

> **NCT06501924** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Applied Biology, Inc.** · enrollment: 516 (estimated)

## Conditions studied

- Androgenetic Alopecia
- Female Pattern Baldness
- Male Pattern Baldness

## Interventions

- **DIETARY_SUPPLEMENT:** DA-005
- **DRUG:** Topical minoxidil 5%
- **DRUG:** DA-002
- **DIETARY_SUPPLEMENT:** Placebo Oral Tablet
- **OTHER:** Placebo Topical Solution

## Key facts

- **NCT ID:** NCT06501924
- **Lead sponsor:** Applied Biology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2025-10-17
- **Final completion:** 2025-12-12
- **Target enrollment:** 516 (ESTIMATED)
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501924, "Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06501924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*